Xilio Therapeutics Inc (XLO)
1.05
-0.02
(-1.87%)
USD |
NASDAQ |
May 24, 16:00
1.05
0.00 (0.00%)
After-Hours: 20:00
Xilio Therapeutics Total Liabilities (Quarterly): 56.84M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 56.84M |
| December 31, 2023 | 24.10M |
| September 30, 2023 | 25.34M |
| June 30, 2023 | 24.98M |
| March 31, 2023 | 26.71M |
| December 31, 2022 | 33.52M |
| September 30, 2022 | 31.12M |
| Date | Value |
|---|---|
| June 30, 2022 | 33.91M |
| March 31, 2022 | 30.23M |
| December 31, 2021 | 32.63M |
| September 30, 2021 | 257.18M |
| June 30, 2021 | 261.33M |
| December 31, 2020 | 119.60M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
24.10M
Minimum
Dec 2023
261.33M
Maximum
Jun 2021
73.65M
Average
32.63M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences Inc | 38.84B |
| FibroGen Inc | 552.02M |
| Avalo Therapeutics Inc | 224.81M |
| IGM Biosciences Inc | 214.88M |
| AEON Biopharma Inc | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 82.61M |
| Shareholders Equity (Quarterly) | 25.76M |